Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sam-A Pharmaceutical Co., Ltd. (009300:KRX), powered by AI.
Sam-A Pharmaceutical Co., Ltd. is currently trading at ₩13,800. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sam-A Pharmaceutical Co., Ltd. on Alpha Lenz.
Sam-A Pharmaceutical Co., Ltd.'s P/E ratio is 6.8.
“Sam-A Pharmaceutical Co., Ltd. trades at a P/E of 6.8 (undervalued) with modest ROE of 5.8%.”
Ask for details →Sam-A Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, renowned for its role in developing, manufacturing, and distributing a wide array of medicinal products. This company primarily focuses on the production of prescription drugs, over-the-counter (OTC) medications, and medical supplies, catering to various therapeutic areas. Its extensive portfolio is designed to address a multitude of health conditions, enhancing patient care and contributing to public health. Operating in South Korea, Sam-A Pharmaceutical leverages advanced research and development capabilities to innovate and introduce effective medical solutions. The company serves both domestic and international markets, highlighting its commitment to expanding its global footprint and increasing access to quality healthcare products. Sam-A Pharmaceutical plays a significant role in the healthcare sector, notably impacting areas such as chronic disease management and preventive medicine. By continually investing in cutting-edge technology and collaborating with global research entities, the firm has secured its position as a key contributor to the pharmaceutical industry's growth and resilience. Its market presence underscores the critical importance of pharmaceuticals in improving and sustaining health outcomes worldwide.
“Sam-A Pharmaceutical Co., Ltd. trades at a P/E of 6.8 (undervalued) with modest ROE of 5.8%.”
Ask for details →Sam-A Pharmaceutical Co., Ltd. (ticker: 009300) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $87.9B.
The current price is ₩13,800 with a P/E ratio of 6.79x and P/B of 0.39x.
ROE is 5.78% and operating margin is 14.11%. Annual revenue is $77.8B.